At Edge, we offer a wide variety of peptides, which are naturally occurring biological molecules, joined by peptide bonds. Peptides are found in all living organisms and play a key role in biological activity as they are in every cell and tissue in the body. CJC-1295 is one of the many peptides offered at Edge. It is a synthetic growth hormone-releasing hormone. Basically, CJC-1295 can help people over 30 have more energy, faster metabolism, and stay in better shape. It is used to treat muscle disorders, burns, and a variety of diseases. CJC-1295 is commonly combined with Impamorelin to stimulate muscle development, increase muscle mass and strength, decrease body fat, improve recovery time from injury, and improve sleep quality, and cognitive function. These peptides work by stimulating the release of hormones by the pituitary gland – a natural process that declines with age.
Human growth hormone is not just essential for growth! Because of its decline in production as we age, it is linked to many of the characteristics of “getting older” such as decreased energy, difficulty losing weight or maintaining weight, decreased strength and muscle mass, and a compromised immune system.
The benefit of using peptides as opposed to synthetic growth hormones is that peptides stimulate your body to produce growth hormones naturally. Our pituitary gland reduces its production of growth hormone as we age, so stimulating it to release the hormone is much safer and can restore the gland to previous production levels even later in life. Injecting a synthetic HGH further decreases the pituitary gland’s ability to release the hormone naturally. There are also many negative side effects associated with synthetic HGH. Since peptides are naturally occurring biological molecules, they can be used quite safely as long as you adhere to the proper dosing and administration instructions.
For more information about CJC-1295, Impamorelin or any of the other peptides offered at Edge, give us a call at 832-789-4989 and schedule a consultation.
